Hamilton Thorne Announces 2013 Fourth Quarter and Year-End Financial Results
Marketwire Canada - Tue Apr 29, 7:26AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the fourth quarter and year-ended December 31, 2013.
Hamilton Thorne Releases New Image Analysis Software for Fertility, Research and Animal Breeding Markets
Marketwire - Tue Apr 22, 3:31PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the release of Version 1.5 of its CASA II sperm analysis software. First released to the animal breeding market in late 2012 and introduced to the fertility market at the European Society of Human Reproduction and Embryology (ESHRE) annual meeting in July 2013, the CASA II software is a complete revitalization of the Company's legacy CASA software. The redesigned software interface provides users with a streamlined workflow and offers automated features to enhance analysis accuracy and ease of use.
Hamilton Thorne Announces Stock Option Grants
Marketwire Canada - Fri Mar 21, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has granted a total of 1,450,000 stock options to purchase common shares pursuant to the Company's incentive stock option plan. The options are exercisable at Cdn$0.05 per share, and expire ten years from the date of grant. A total of 1,100,000 of these options were granted to the Company's Directors, CEO, CTO and CFO. Grants to non-employee Directors vest over three years; grants to employees vest over four years.
Hamilton Thorne Announces Preliminary 2013 Financial Results
Marketwire - Thu Feb 13, 7:30AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2013.
Hamilton Thorne Announces 2013 Third Quarter Financial Results
Marketwire Canada - Wed Nov 27, 7:05AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the third quarter and nine month period ended September 30, 2013.
Hamilton Thorne Announces 2013 Second Quarter Financial Results
Marketwire Canada - Mon Aug 26, 3:05PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the second quarter and six months year-to-date ended June 30, 2013.
Hamilton Thorne Announces 2013 First Quarter Financial Results
Marketwire Canada - Tue May 28, 7:30AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the first quarter ended March 31, 2013.
Hamilton Thorne Announces Preliminary 2012 Fourth Quarter Financial Results
Marketwire Canada - Mon Feb 11, 3:30PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2012.